China Catalyst (688267) review: Q3 profits were affected by the month-on-month decline in denitrification zeolite sales, and the share of catalysts increased
China Catalyst (688267): Downstream demand continues to improve 2024Q3 net profit surges year-on-year
China Catalyst (688267): Denitrification zeolite has recovered, and catalyst varieties have gradually started, and the performance has slightly exceeded expectations
China Catalyst (688267): The company's performance increased year-on-year, and I am optimistic that mobile source denitrification molecular sieve product upgrades and fund-raising projects will gradually reach production
China Catalyst (688267): 1H24 performance is in line with expectations, the company's product line continues to expand
China Catalyst (688267): 23 years deduction of non-net profit -58% YoY -58% 24Q1 deducted non-net profit YoY +2690%
China Catalyst (688267): 1Q24 company performance recovery, optimistic about continuous optimization of the company's product structure
China Catalyst (688267) review: Denitrification zeolite sales have clearly rebounded, and future catalysts will blossom more
Guohai Securities released a research report on April 25 stating that it gave China Catalyst (688267.SH) a buy rating. The main reasons for the rating include: 1) downstream demand gradually recovered, and the company's performance in the first quarter of
China Catalyst (688267): Results for the first quarter of 2024 surged year-on-year, and the fund-raising project progressed smoothly
China Catalyst (688267): Performance improved month-on-month due to a recovery in overseas demand for denitrification molecular sieves
China Catalyst (688267): Mobile Source Denitrification and Titanium-Silicon Zeolite, one of the leading domestic molecular sieve catalysts, two core products promote the company's steady development
China Catalyst (688267): Performance falls short of expectations, denitrification molecular sieve orders need to be resumed
China Catalyst (688267): 1H23 performance is in line with expectations, denitrification molecular sieve sales volume is under pressure
China Catalyst (688267): Q4 performance hits a record high in a single quarter, increasing the layout of new environmentally friendly materials
China Catalyst (688267): The performance report is in line with expectations, and the new product layout saves growth momentum
China Catalyst (688267): New products such as metocresol are moving towards platform-based companies
China Catalyst (688267): Major customer BASF signs procurement agreement to greatly increase company growth space
China Catalyst (688267): Expanding the molecular sieve business to global performance is expected to continue to rise
China Catalyst (688267): The turmoil of the epidemic is easing equity incentives, showing confidence in growth